| |
Intervention
|
Control
| |
|---|
|
Clinical topic
|
n
|
Mean before (sd)
|
Mean after (sd)
|
n
|
Mean before (sd)
|
Mean after (sd)
|
Ba (95% CI)
|
icc
|
Direction
|
p
|
|---|
|
Anaemia
|
39
|
177.8 (173.1)
|
208.4 (216.9)
|
49
|
208.1 (148.7)
|
247.3 (176.7)
|
15.3 (−53.7, 83.3)
|
0.31
|
↓
|
0.630
|
|
Rheumatic complaints
|
39
|
12.9 (20.1)
|
13.1 (23.0)
|
49
|
12.9 (16.2)
|
15.0 (27.5)
|
2.9 (−9.0, 14.9)
|
0.31
|
↓
|
0.581b
|
|
Prostate complaints
|
39
|
34.4 (28.0)
|
36.1 (26.2)
|
49
|
37.6 (27.9)
|
40.7 (31.0)
|
1.8 (−4.9, 8.6)
|
0.04
|
↓
|
0.575
|
|
Chlamydia infections
|
49
|
9.9 (15.4)
|
8.9 (19.5)
|
39
|
7.8 (9.6)
|
6.3 (10.0)
|
2.2 (−9.5, 13.9)
|
0.74
|
↑
|
0.701
|
|
Thyroid dysfunction
|
49
|
178.9 (139.0)
|
206.1 (155.4)
|
39
|
160.6 (158.3)
|
186.1 (151.7)
|
3.9 (−26.3, 34.11)
|
0.03
|
↓
|
0.788
|
|
Perimenopausal complaints
|
49
|
5.6 (6.2)
|
5.2 (6.0)
|
39
|
6.4 (7.6)
|
7.4 (8.5)
|
−1.4 (−5.0, 2.1)
|
0.29
|
↓
|
0.404
|
- The desired direction of change is given in the column headed ‘Direction’. Numbers represent the number of tests prescribed per 6 months per 1000 patients
-
n = number of practices
-
aAdjusted difference between groups at end of intervention, corrected for baseline
-
bStatistically significant interaction
- Rheumatic complaints
- P 10: B (95% CI):−7.8 (−22.0, 6.5). p: 0.257
- P 90: B (95% CI): 16.3 (1.7, 30.9). p: 0.031
